Latham & Watkins advised Advanced Micro Devices – AMD on the acquisition Of ZT Systems advised by Paul Weiss. AMD (NASDAQ: AMD) signed a definitive agreement...
You must be a Standard 1 Year member to access this content.
Skadden is advising Otsuka, while Latham & Watkins is advising Jnana on the deal. Nutraceutical and pharmaceutical company Otsuka Holdings Co. Ltd., (Otsuka), announced the definitive...
You must be a Standard 1 Year member to access this content.
Haynes and Boone represented Serenity Kids in the transaction, and Latham & Watkins represented Stride Consumer Partners. Serenity Kids, a shelf-stable pouched baby food brand, announced...
You must be a Standard 1 Year member to access this content.
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised AbbVie, Latham & Watkins advised Cerevel Therapeutics, Skadden advised Centerview partners LLC, as financial advisor to Cerevel Therapeutics in the transaction. AbbVie...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises WestView Capital Partners in its investment in Hubstaff WestView Capital Partners made a strategic investment in Hubstaff as the workforce management software company capitalizes...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Performance Livestock Analytics in funding and separation from Zoetis. Performance Livestock Analytics (PLA), an independent precision livestock platform using cattle data and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Pionyr on the sale. Ikena Oncology, Inc. (Nasdaq: IKNA, Ikena) and Pionyr Immunotherapeutics, Inc. have announced the closing of Ikena’s acquisition of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell and Paul Hastings LLP are advising Francisco Partners and TPG, and Latham & Watkins LLP is advising New Relic on the transaction....
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Cadence, and Wilson Sonsini Goodrich & Rosati advised Rambus on the transaction. Cadence Design Systems, Inc. and Rambus Inc. announced that they have entered...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Alpha II and existing shareholder WestView Capital Partners on TA Associates strategic Growth investment. TA Associates, a leading global private equity firm,...
You must be a Standard 1 Year member to access this content.
